The influence of family history of
cancer,
radiation therapy and anticancer
drug therapy (
mitomycin C) on the occurrence of
multiple primary neoplasms, following treatment of a first primary
cancer of the breast, was analyzed by the person-year method in 1,359 patients, in Japan. During 14,371.8 person-years of observation, 111
multiple primary neoplasms including bilateral breast
cancers were found in 109 patients. The incidence rate of
multiple primary neoplasms were 0.00772 per person-year. The incidence in patients with a family history of
cancer was 1.29 times greater than that in patients without such a family history, and the incidence in patients with a family history of
breast cancer was about three times greater than that in those without it (p less than 0.01).
Radiation therapy raised the occurrence of subsequent primary
neoplasms 1.28-fold (or 1.62 fold after 5 years), and
mitomycin C (a total dose of 0.8 mg/kg)
therapy caused no increase in the occurrence of subsequent primary
cancers, after an observation of 10 years or so.